Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Concurrent Chemoradiotherapy in Locoregionally Advanced NPC
NCT02907710Phase 3Unknown
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Oct 2016
- Primary completion
- Nov 2018
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of endostar in nasopharyngeal carcinoma (NPC), sponsored by The First Affiliated Hospital of Guangxi Medical University. Status: unknown.
02
Drugs
endostar
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02907710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02907710.